The DEA will begin cannabis rescheduling on January 21, potentially lowering its classification to Schedule III for medical prescriptions. However, Trump’s presidency and Republican majorities dim...
Despite warnings against investing in pot market, the cannabis industry is one to follow because it is set to explode in the coming years.